Atlas Trials

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

Clinical trial NCT06021197 · RECRUITING

Trial details

NCT number
NCT06021197
Sponsor
China Medical University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2023-10-12
Primary completion
2027-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.